Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis

Leishmaniasis is a neglected tropical disease affecting more than 12 million people worldwide, which in its visceral clinical form (VL) is characterised by the accumulation of parasites in the liver and spleen, and can lead to death if not treated. Available treatments are not well tolerated due to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Pharmaceutics
Huvudupphovsmän: Bezerra-Souza, Adriana, Fernandez-Garcia, Raquel, Rodrigues, Gabriela F., Bolas-Fernandez, Francisco, Dalastra Laurenti, Marcia, Passero, Luiz Felipe, Lalatsa, Aikaterini, Serrano, Dolores R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6680852/
https://ncbi.nlm.nih.gov/pubmed/31330776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11070353
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk